Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase Ib dose finding study of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765) plus Lenalidomide/Rituximab in Relapsed or Refractory Mantle Cel Lymphoma (MCL)
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.